These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25008182)

  • 1. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy.
    Goldberg R; Rubinstein AM; Gil N; Hermano E; Li JP; van der Vlag J; Atzmon R; Meirovitz A; Elkin M
    Diabetes; 2014 Dec; 63(12):4302-13. PubMed ID: 25008182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase is essential for the development of diabetic nephropathy in mice.
    Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M
    Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration.
    Kang MK; Li J; Kim JL; Gong JH; Kwak SN; Park JH; Lee JY; Lim SS; Kang YH
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1060-9. PubMed ID: 22791342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
    Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
    J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin L is crucial for the development of early experimental diabetic nephropathy.
    Garsen M; Rops AL; Dijkman H; Willemsen B; van Kuppevelt TH; Russel FG; Rabelink TJ; Berden JH; Reinheckel T; van der Vlag J
    Kidney Int; 2016 Nov; 90(5):1012-1022. PubMed ID: 27575559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.
    Chow FY; Nikolic-Paterson DJ; Ozols E; Atkins RC; Tesch GH
    J Am Soc Nephrol; 2005 Jun; 16(6):1711-22. PubMed ID: 15857924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.
    Lee SH; Lee TW; Ihm CG; Kim MJ; Woo JT; Chung JH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S32-6. PubMed ID: 16174285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
    Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
    Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
    J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
    Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparanase in diseases of the glomeruli.
    Szymczak M; Kuźniar J; Klinger M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
    Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of C3a receptor attenuates the development of diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000817. PubMed ID: 31798904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.